Jim Cramer
We’re booking profits in a rallying rotation play and using the cash to buy 2 others on the dip
We are making a handful of more trades Tuesday. Selling 75 shares of GE Healthcare at roughly $86 each; following the trade, Jim Cramer’s Charitable Trust will own 550 shares of GEHC, decreasing its weighting to about 1.43% from about 1.62% We are buying 50 shares of TJX at roughly $116; following the trade, the […]
Read More
What Cramer wants to hear from Nvidia, Salesforce — plus, Lilly does what no other can
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. The broader market rebounded Wednesday, with the S & P 500 and Nasdaq trying to snap their four-day losing streaks. The Dow was on pace for its third straight […]
Read More
Cramer’s week ahead: Earnings from Nvidia, Dell and Home Depot
CNBC’s Jim Cramer on Friday walked investors through next week on Wall Street and highlighted earnings reports from Home Depot as well as tech giants Nvidia and Dell. He also discussed the market’s decline over the past few sessions — especially the poor performance of formerly-hot growth stocks — predicting investors haven’t seen the end […]
Read More
How the world’s largest asset manager is using nearly $28 billion of acquisitions to reinvent itself
BlackRock has been on a buying spree that will change the makeup of the world’s biggest asset manager. BlackRock announced last year a slew of high-profile acquisitions — including a $12 billion deal to buy private credit manager HPS Investment Partners (HPS), which is expected to close in mid-2025; a $12.5 billion purchase of infrastructure […]
Read More
GE Healthcare soars 9% on earnings beat, wise guidance. Here’s our new price target
Things continue to look up for GE Healthcare stock this year. Shares of the medical technology company jumped roughly 9% on Thursday after delivering solid fourth-quarter results and providing prudent 2025 guidance. While the Club stock left much to be desired in 2024, these numbers boosted shares that were already bouncing off their most recent […]
Read More
We’re adding to our position in a sliding stock and booking profits in a 2025 winner
We’re making a pair of trades Monday as Wall Street rallies to kick off the week. Source
Read More
Bristol Myers’ stock decline in response to weak guidance is a gift to investors
Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares lower. Jim Cramer’s faith in the drugmaker is unshaken. Revenue in the fourth quarter rose 8% year over year to $12.34 billion, well ahead of the $11.57 billion consensus, according to analysts’ estimates compiled by LSEG. Adjusted earnings per […]
Read More
Columbia Sportswear CEO talks tariff impact: ‘We need some surety about what’s going to happen’
In a Wednesday interview with CNBC’s Jim Cramer, Columbia Sportswear CEO Tim Boyle said his company needs more clarity about global tariff decisions in order to plan for what’s to come. “It’s a dampening effect,” he said. “But, more importantly, we need some surety about what is going to happen, what’s the future.” President Donald […]
Read More
We’re making 4 trades, including an exit and an initiation, to reduce our tariff risk
Looking to reduce our exposure to tariffs and China, we’re making changes in the portfolio. We’re exiting our position in Stanley Black & Decker , selling our remaining 510 shares at roughly $86.79 each. We’re buying 50 shares of Home Depot at roughly $409.60. Following the trade, Jim Cramer’s Charitable Trust will own 300 shares […]
Read More
Flexport CEO breaks down the complex and uncertain global trade landscape
As the market reels from ever-changing news about President Donald Trump’s tariff hikes, Flexport CEO Ryan Petersen detailed how his customers are dealing with a volatile global trade environment in a Monday interview with CNBC’s Jim Cramer. “It’s very hard to plan a supply chain when it’s changing day to day, so I think it’s […]
Read More